Renaissance Technologies’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,700,438
| Closed | -$1.79M | – | 3888 |
|
|
2020
Q4 | $1.79M | Sell |
3,700,438
-123,908
| -3% | -$62.6K | ﹤0.01% | 2184 |
|
|
2020
Q3 | $2.08M | Sell |
3,824,346
-487,717
| -11% | -$351K | ﹤0.01% | 2104 |
|
|
2020
Q2 | $2.98M | Sell |
4,312,063
-25,210
| -0.6% | -$20.3K | ﹤0.01% | 1943 |
|
|
2020
Q1 | $3.65M | Buy |
4,337,273
+169,988
| +4% | +$243K | ﹤0.01% | 1745 |
|
|
2019
Q4 | $6.83M | Buy |
4,167,285
+245,755
| +6% | +$369K | 0.01% | 1678 |
|
|
2019
Q3 | $4.35M | Buy |
3,921,530
+247,419
| +7% | +$286K | ﹤0.01% | 1872 |
|
|
2019
Q2 | $4.56M | Buy |
3,674,111
+307,700
| +9% | +$392K | ﹤0.01% | 1864 |
|
|
2019
Q1 | $4.85M | Buy |
3,366,411
+313,000
| +10% | +$464K | ﹤0.01% | 1831 |
|
|
2018
Q4 | $3.6M | Buy |
3,053,411
+157,800
| +5% | +$234K | ﹤0.01% | 1932 |
|
|
2018
Q3 | $3.91M | Buy |
2,895,611
+471,411
| +19% | +$747K | ﹤0.01% | 1953 |
|
|
2018
Q2 | $5.55M | Buy |
2,424,200
+863,600
| +55% | +$1.67M | 0.01% | 1719 |
|
|
2018
Q1 | $2.36M | Buy |
1,560,600
+366,500
| +31% | +$429K | ﹤0.01% | 2245 |
|
|
2017
Q4 | $911K | Buy |
1,194,100
+346,400
| +41% | +$310K | ﹤0.01% | 2694 |
|
|
2017
Q3 | $983K | Sell |
847,700
-19,000
| -2% | -$23.9K | ﹤0.01% | 2580 |
|
|
2017
Q2 | $1.51M | Buy |
866,700
+179,700
| +26% | +$382K | ﹤0.01% | 2407 |
|
|
2017
Q1 | $1.81M | Buy |
687,000
+369,400
| +116% | +$1.33M | ﹤0.01% | 2296 |
|
|
2016
Q4 | $1.35M | Buy |
317,600
+200,200
| +171% | +$660K | ﹤0.01% | 2412 |
|
|
2016
Q3 | $313K | Buy |
117,400
+105,000
| +847% | +$241K | ﹤0.01% | 2942 |
|
|
2016
Q2 | $22K | Sell |
12,400
-19,700
| -61% | -$40.2K | ﹤0.01% | 3279 |
|
|
2016
Q1 | $74K | Sell |
32,100
-255,378
| -89% | -$578K | ﹤0.01% | 3246 |
|
|
2015
Q4 | $998K | Buy |
287,478
+9,878
| +4% | +$47.3K | ﹤0.01% | 2460 |
|
|
2015
Q3 | $1.7M | Buy |
277,600
+23,700
| +9% | +$161K | ﹤0.01% | 2099 |
|
|
2015
Q2 | $1.68M | Buy |
253,900
+40,900
| +19% | +$276K | ﹤0.01% | 2178 |
|
|
2015
Q1 | $1.52M | Buy |
+213,000
| New | +$1.61M | ﹤0.01% | 2082 |
|
Other funds holding GEN
IC
TRCT
Renaissance Technologies's GEN Position: Q1 2021 in Review
Renaissance Technologies sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 3,700,438 shares — an estimated $1.79M sold.
Renaissance Technologies first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $6.83M in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Renaissance Technologies reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Renaissance Technologies sold 3,700,438 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $1.79M.
- Renaissance Technologies first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Renaissance Technologies's Genesis Healthcare, Inc. position peaked at $6.83M in Q4 2019.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.